RISEN (SUZHOU) PHARMA TECH CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for RISEN (SUZHOU) PHARMA TECH CO., LTD..The latest application filed is for "prodrugs of a cdk inhibitor for treating cancers".

Company Profile

11.10.15

RISEN (SUZHOU) PHARMA TECH CO., LTD. - Suzhou CN
RISEN (SUZHOU) PHARMA TECH CO., LTD. - Suzhou, Jiangsu CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prodrugs Of A Cdk Inhibitor For Treating Cancers App 20220204541 - LU; Jiasheng ; et al.	2022-06-30
Isotope-enriched 3-amino-1-propanesulfonic Acid Derivatives For The Treatment Of Cerebrovascular Disease App 20220202778 - LU; Jiasheng ; et al.	2022-06-30
Crystalline Form Of 3- ((l-valyl) Amino)) -3, 3-dideuterium-1-propanesulfonic Acid, Preparation Method And Uses Thereof App 20220144766 - LU; Jiasheng ; et al.	2022-05-12
Prodrugs of a CDK inhibitor for treating cancers Grant 11,225,497 - Lu , et al. January 18, 2	2022-01-18
A Crystalline Form Of 3- ((l-valyl) Amino) -1-propanesulfonic Acid App 20220002239 - LU; Jiasheng ; et al.	2022-01-06
Stable Heavy Isotopes In Amide Functional Groups And Uses Thereof App 20220002285 - LU; Jiasheng ; et al.	2022-01-06
Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof Grant 11,186,543 - Lu , et al. November 30, 2	2021-11-30
Isotope-enriched 3-amino-1-propanesulfonic Acid Derivatives And Uses Thereof App 20210347731 - LU; Jiasheng ; et al.	2021-11-11
Cd73 Inhibitors And Pharmaceutical Uses Thereof App 20210139526 - LU; Jiasheng ; et al.	2021-05-13
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof Grant 10,954,188 - Lu , et al. March 23, 2	2021-03-23
Prodrugs Of The Tyrosine Kinase Inhibitor For Treating Cancer App 20210078970 - LU; Jiasheng ; et al.	2021-03-18
Glucosamine Derivatives For The Prevention Or Treatment Of Joint Disorders App 20210079033 - KONG; Xianqi ; et al.	2021-03-18
Crystalline Form Of 3- ((l-valyl) Amino)) -3, 3-dideuterium-1-propanesulfonic Acid, Preparation Method And Uses Thereof App 20210053914 - LU; Jiasheng ; et al.	2021-02-25
CD73 inhibitors and pharmaceutical uses thereof Grant 10,881,681 - Lu , et al. January 5, 2	2021-01-05
Prodrugs Of A Cdk Inhibitor For Treating Cancers App 20200339615 - LU; Jiasheng ; et al.	2020-10-29
Isotope-enriched 3-amino-1-propanesulfonic Acid Derivatives And Uses Thereof App 20200223793 - LU; Jiasheng ; et al.	2020-07-16
Cd73 Inhibitors And Pharmaceutical Uses Thereof App 20200078388 - LU; Jiasheng ; et al.	2020-03-12
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof Grant 10,472,323 - Lu , et al. Nov	2019-11-12
Glucosamine Derivatives And Pharmaceutical Uses Thereof App 20190185502 - LU; Jiasheng ; et al.	2019-06-20
Isotope-enriched 3-amino-1-propanesulfonic Acid Derivatives And Uses Thereof App 20180273471 - Lu; Jiasheng ; et al.	2018-09-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.